Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of the Combination of the Natural Products Glizigen® and Ocoxin®-Viusid® in the Treatment of High-grade Cervical Intraepithelial Lesions. Phase II

NCT03549273 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT03549273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03549273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of the Combination of the Natural Products Glizigen® and Ocoxin®-Viusid® in the Treatment of High-grade Cervical Intraepithelial Lesions. Phase II
Lead sponsor
Catalysis SL
Phase
Phase 2
Overall status
Unknown status
Start date
March 11, 2019
Completion date
January 15, 2025
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, epithelial neoplasm, glandular neoplasms, neoplasia; intraepithelial, cervix, neoplasms